Esbriet
Payments companies reported to CMS as associated with Esbriet. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Esbriet, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Esbriet
These are the largest totals companies reported as associated with Esbriet. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Marilyn Glassberg | Maywood, IL | Pulmonary Disease | $255.39 |
| Marc Csete | Miami Beach, FL | Pulmonary Disease | $255.39 |
| Ayodeji Adegunsoye | Chicago, IL | Pulmonary Disease | $165.73 |
| Lisa Lancaster | Nashville, TN | Pulmonary Disease | $153.97 |
| Cedric Franklin Rutland | Riverside, CA | Critical Care Medicine (Internal Medicine) | $150.00 |
| Samuel Louie | Sacramento, CA | Pulmonary Disease | $124.90 |
| Yuh Chin Huang | Durham, NC | Critical Care Medicine (Internal Medicine) | $124.90 |
| Anas Hadeh | Weston, FL | Pulmonary Disease | $124.90 |
| Brooks Kuhn | Sacramento, CA | Pulmonary Disease | $124.90 |
| David Mannino | Lexington, KY | Internal Medicine | $124.90 |
Prescribed Esbriet?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.